Singapore, Singapore

Hui Ting Toh

This inventor holds 2 USPTO granted patents. Top assignee: Nanyang Technological University. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hui Ting Toh. Retrieved from https://idiyas.com/inventor/hui-ting-toh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hui Ting Toh: Innovator in Nurr1 Modulation

Introduction

Hui Ting Toh is a prominent inventor based in Singapore, known for his contributions to the field of biochemistry and pharmacology. He has been instrumental in developing innovative solutions that target the Nuclear receptor related 1 protein, which plays a crucial role in various biological processes.

Latest Patents

Hui Ting Toh holds 2 patents related to co-crystals of NURR1-lbd in complex with cyclopentenone prostaglandins. His latest patents provide methods for identifying or designing Nurr1-modulating ligands and compounds based on the described crystal structures. These ligands and compounds have significant applications as Nurr1 modulators or medicaments, showcasing the potential for therapeutic advancements.

Career Highlights

Hui Ting Toh is affiliated with Nanyang Technological University, where he continues to push the boundaries of research in his field. His work has garnered attention for its innovative approach to drug design and molecular biology.

Collaborations

He collaborates with notable colleagues such as Ho Sup Yoon and Sreekanth Rajan, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Hui Ting Toh's work exemplifies the intersection of scientific research and practical application, making significant strides in the development of Nurr1 modulators. His contributions are paving the way for future advancements in medicinal chemistry and therapeutic interventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…